Circulating vitamin D correlates with serum antimüllerian hormone levels in late- reproductive-aged women: Women's Interagency HIV Study  Zaher O. Merhi,

Slides:



Advertisements
Similar presentations
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Advertisements

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Longitudinal depressive symptoms and state anxiety among women using assisted reproductive technology  Anjel Vahratian, Ph.D., M.P.H., Yolanda R. Smith,
Age at menarche: a predictor of diminished ovarian function?
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Infertility evaluation and treatment among women in the United States
H. Irene Su, M. D. , M. S. C. E. , Mary D. Sammel, Sc. D. , Michael V
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Michael M. Alper, M.D.  Fertility and Sterility 
Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women  David B. Seifer, M.D., Elizabeth.
The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women 
Ramifications of adolescent menstrual cycles ≥42 days in young adults
Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J
The spectrum of androgen excess disorders
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause  Linlin Cui, M.D., Ph.D., Yingying.
Robot-assisted laparoscopy for infertility treatment: current views
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids  Isabelle.
Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females  Josephine Z. Kasa-Vubu, M.D., Vandana.
Orhan Bukulmez, M. D. , Qin Li, M. S. , Bruce R. Carr, M. D
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
A comparison of blood spot vs
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.
Ellen W. Freeman, Ph. D. , Clarisa R. Gracia, M. D. , Mary D
Low fertility awareness in United States reproductive-aged women and medical trainees: creation and validation of the Fertility & Infertility Treatment.
Oocyte cryopreservation
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis  Reshef Tal,
Clomiphene citrate at 50: the dawning of assisted reproduction
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Increased secretion of amylin in women with polycystic ovary syndrome
“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss  Michelle.
In vitro fertilization and breast cancer: is there cause for concern?
Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D
Association of adolescent obesity and lifetime nulliparity—The Study of Women's Health Across the Nation (SWAN)  Alex J. Polotsky, M.D., M.S., Susan M.
Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment  Richard Fleming, Ph.D.,
Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D
David B. Seifer, M. D. , Elizabeth T. Golub, Ph. D
Serum and follicular fluid monocyte chemotactic protein-1 levels are elevated in obese women and are associated with poorer clinical pregnancy rate after.
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men  Subodhsingh Chauhan, M.D.,
Association of vitamin D intake and serum levels with fertility: results from the Lifestyle and Fertility Study  June L. Fung, Ph.D., Terryl J. Hartman,
Fertility and Sterility: an evaluation
Paolo Moghetti, M.D.  Fertility and Sterility 
Rupal Shroff, B. S. , Craig H. Syrop, M. D. , William Davis, M. D
Association of endometriosis with body size and figure
Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome  Yuwen Wu, M.D., Jianhua Zhang,
Current evaluation of amenorrhea
Ariel Fuentes, M. D. , Alex Muñoz, B. S. , Kurt Barnhart, M. D
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
Soluble HLA-G in the peritoneal fluid of women with endometriosis
Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test  Dimitrios Panidis, M.D., Ph.D., Dimitrios.
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles 
Presentation transcript:

Circulating vitamin D correlates with serum antimüllerian hormone levels in late- reproductive-aged women: Women's Interagency HIV Study  Zaher O. Merhi, M.D., David B. Seifer, M.D., Jeremy Weedon, Ph.D., Oluwatoyin Adeyemi, M.D., Susan Holman, R.N., M.S., Kathryn Anastos, M.D., Elizabeth T. Golub, Ph.D., Mary Young, M.D., Roksana Karim, Ph.D., Ruth Greenblatt, M.D., Howard Minkoff, M.D.  Fertility and Sterility  Volume 98, Issue 1, Pages 228-234 (July 2012) DOI: 10.1016/j.fertnstert.2012.03.029 Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 1 A model for regression slope pattern between serum 25OH-D and serum AMH in the WIHS participants after adjusting for HIV status, BMI, race/ethnicity, smoking history, current illicit drug use, fasting glucose, fasting insulin, EGFR, and geographic site of collaboration. Slope is zero at age 35.7 years. ∗P<.05 for women aged ≥40 years. Fertility and Sterility 2012 98, 228-234DOI: (10.1016/j.fertnstert.2012.03.029) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions